CARL
CARL
US14280C1053
Carlsmed, Inc.
Loading chart...

Company Profile

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Latest News

Related stocks

WEAV
WEAV • United States
Weave Communications, Inc.
7.38 USD
593.72M USD 1Y +7.4%
PHR
PHR • United States
Phreesia, Inc.
10.81 USD
670.99M USD 1Y -54.2%
HSTM
HSTM • United States
HealthStream, Inc.
33.13 USD
1.01B USD 1Y +19.5%
TDOC
TDOC • United States
Teladoc Health, Inc.
5.77 USD
1.05B USD 1Y -39.1%
GDRX
GDRX • United States
GoodRx Holdings, Inc.
3.43 USD
1.17B USD 1Y -23.5%
OMDA
OMDA • United States
Omada Health, Inc.
21.55 USD
1.32B USD 1Y -13.2%
CERT
CERT • United States
Certara, Inc.
9.13 USD
1.39B USD 1Y -33.5%
OMCL
OMCL • United States
Omnicell, Inc.
35.82 USD
1.63B USD 1Y +10.7%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
ende